On Air Now

Listen

Listen Live Now » 93.7 FM Sheboygan, WI

Weather

Current Conditions(Sheboygan,WI 53081)

More Weather »
68° Feels Like: 68°
Wind: NW 5 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Today

Scattered Thunderstorms 73°

Tonight

Isolated Thunderstorms 57°

Tomorrow

Partly Cloudy 69°

Alerts

FDA approves Lundbeck's antidepressant Brintellix

(Reuters) - The U.S. Food and Drug Administration approved Lundbeck's antidepressant Brintellix to treat adults with major depressive disorder.

The drug, which Lundbeck will co-market with Japanese partner Takeda Pharmaceutical Co Ltd, will be available in four doses.

Brintellix, like other antidepressants, will carry a boxed warning alerting patients and doctors to an increased risk of suicidal thoughts and behavior in children, adolescents and young adults aged 18-24 during initial treatment.

The most common side effects reported by patients taking the drug — generically known as vortioxetine — include nausea, constipation and vomiting.

Major depressive disorder is characterized by mood changes that may interfere with a person's ability to carry out to day-to-day activities. Symptoms also include increased fatigue and feelings of guilt or worthlessness.

(Reporting By Vrinda Manocha in Bangalore; Editing by Joyjeet Das)

Comments